PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616728
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616728
The Global Microcatheters Market was valued at USD 985.5 million in 2023 and is projected to grow at a CAGR of 5.1% from 2024 to 2032. This growth is largely fueled by rising demand for minimally invasive surgical procedures and technological advancements in catheters. The surge in minimally invasive surgical procedures is a primary catalyst for the market expansion. These surgeries have gained traction due to their advantages over traditional open surgeries, such as quicker recovery times, reduced complication risks, less pain and scarring, and shorter hospital stays. Consequently, there has been a pronounced shift towards minimally invasive surgeries (MIS) across diverse medical fields, including neurology, cardiology, oncology, and peripheral vascular treatments.
The industry is divided into product, design, application, end-use, and region. The market segments products into delivery microcatheters, diagnostic microcatheters, aspiration microcatheters, and steerable microcatheters. Notably, the steerable segment is projected to grow the fastest, at a 5.3% CAGR. This surge is attributed to their rising use in cardiovascular angiography, where they offer enhanced success rates and shorter procedural times compared to standard microcatheters.
Their unique feature allows real-time angulation adjustments, boosting the efficiency of super-selective vessel cannulation. Applications of microcatheters span cardiovascular, neurovascular, peripheral vascular, oncology, and more. The cardiovascular segment dominated the market, raking in approximately USD 401.2 million in 2023. This prominence is largely due to the escalating global incidence of cardiovascular disorders (CVDs). The World Health Organization (WHO) highlights the gravity, noting CVDs as the top global death cause, accounting for over 30% of all deaths.In 2023, North America generated a substantial USD 331.4 million in microcatheter revenue. This robust figure is driven by a rising prevalence of neurovascular and cardiovascular diseases and an uptick in percutaneous coronary intervention procedures. Furthermore, bolstering this growth are government initiatives, a network of established healthcare facilities, and the ready availability of advanced technological products.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $985.5 Million |
Forecast Value | $1.6 Billion |
CAGR | 5.1% |